Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f*

Abstract

Quantitative magnetization transfer magnetic resonance imaging (qMT-MRI) can be used to improve detection of white matter tissue damage in multiple sclerosis (MS) and animal models thereof. To study the correlation between MT parameters and tissue damage, the magnetization transfer ratio (MTR), the parameter f* (closely related to the bound proton fraction) and the bound proton transverse relaxation time T_2B of lesions in a model of focal experimental autoimmune encephalomyelitis (EAE) were measured on a 7T animal scanner and data were compared with histological markers indicative for demyelination, axonal density, and tissue damage. A clear spatial correspondence was observed between reduced values of MTR and demyelination in this animal model. We observed two different levels of MTR and f* reduction for these lesions. One was characterized by a pronounced demyelination and the other corresponded to a more severe loss of the cellular matrix. Changes in f* were generally more pronounced than those of MTR in areas of demyelination. Moreover, a reduction of f* was already observed for tissue where MTR was virtually normal. No changes in T_2B were observed for the lesions. We conclude that MTR and qMT mapping are efficient and reliable readouts for studying demyelination in animal models of MS, and that the analysis of regional f* might be even superior to the analysis of MTR values. Therefore, quantitative mapping of f* from human brains might also improve the detection of white matter damage in MS.

Keywords

quantitative magnetization transfer EAE focal lesion magnetic resonance imaging

Get full access to this article

View all access options for this article.

References

1 Rovaris M Gass A Bammer R . Diffusion MRI in multiple sclerosis. Neurology 2005; 65: 1526–1532.

2 Henkelman RM Stanisz GJ Graham SJ . Magnetization transfer in MRI: a review. NMR Biomed 2001; 14: 57–64.

3 Stankoff B Wang YM Bottlaender M . Imaging of CNS myelin by positron-emission tomography. Proc Natl Acad Sci U S A 2006; 103: 9304–9309.

4 Filippi M Falini A Arnold DL . Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group. J Magn Reson Imaging 2005; 21: 669–675.

5 Cercignani M Iannucci G Rocca MA Comi G Horsfield MA Filippi M . Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 2000; 54: 1139–1144.

6 Horsfield MA Barker GJ Barkhof F Miller DH Thompson AJ Filippi M . Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J Magn Reson Imaging 2003; 17: 389–397.

7 Filippi M Rocca MA . Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve. Neurotherapeutics 2007; 4: 401–413.

8 Ramani A Jensen JH Helpern JA . Quantitative MR imaging in Alzheimer disease. Radiology 2006; 241: 26–44.

9 Ridha BH Symms MR Lewis EB . Magnetization transfer imaging of the hippocampal formation: application to Alzheimer's disease. Neurobiol Aging 2004; 25: S270–S270.

10.

10 Ridha BH Tozer DJ Symms MR . Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007; 244: 832–837.

11.

11 Ridha BH Symms MR Tozer DJ . Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. AJNR Am J Neuroradiol 2007; 28: 965–970.

12.

12 Graham SJ Henkelman RM . Understanding pulsed magnetization transfer. J Magn Reson Imaging 1997; 7: 903–912.

13.

13 Henkelman RM Huang XM Xiang QS Stanisz GJ Swanson SD Bronskill MJ . Quantitative interpretation of magnetization-transfer. Magn Reson Med 1993; 29: 759–766.

14.

14 Kita M Goodkin DE Bacchetti P Waubant E Nelson SJ Majumdar S . Magnetization transfer ratio in new MS lesions before and during therapy with IFN beta-1a. Neurology 2000; 54: 1741–1745.

15.

15 Fox RJ Fisher E Tkach J Lee JC Cohen JA Rudick RA . Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications. Mult Scler 2005; 11: 140–145.

16.

16 Inglese M van Waesberghe JHTM Rovaris M . The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. Neurology 2003; 60: 853–860.

17.

17 Zivadinov R . Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis. Neurology 2007; 68: S72–S82.

18.

18 Pike GB de Stefano N Narayanan S Francis GS Antel JP Arnold DL . Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol 1999; 20: 829–837.

19.

19 Tozer D Ramani A Barker GJ Davies GR Miller DH Tofts PS . Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. Magn Reson Med 2003; 50: 83–91.

20.

20 Tozer DJ Davies GR Altmann DR Miller DH Tofts PS . Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. Magn Reson Med 2005; 53: 1415–1422.

21.

21 Berry I Barker GJ Barkhof F . A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging 1999; 9: 441–446.

22.

22 Tofts PS Steens SCA Cercignani W . Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differences. MAGMA 2006; 19: 209–222.

23.

23 Bruck W Bitsch A Kolenda H Bruck Y Stiefel M Lassmann H . Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783–793.

24.

24 Schmierer K Tozer DJ Scaravilli F . Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn Reson Imaging 2007; 26: 41–51.

25.

25 Ramani A Dalton C Miller DH Tofts PS Barker GJ . Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times. Magn Reson Imaging 2002; 20: 721–731.

26.

26 Swanson LW . Brain maps. Amsterdam: Elsevier; 1998.

27.

27 Cercignani M Alexander DC . Optimal acquisition schemes for in vivo quantitative magnetization transfer MRI. Magn Reson Med 2006; 56: 803–810.

28.

28 McDonald WI Compston A Edan G . Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–127.

29.

29 Stanisz GJ Webb S Munro CA Pun T Midha R . MR properties of excised neural tissue following experimentally induced inflammation. Magn Reson Med 2004; 51: 473–479.

30.

30 Sled JG Pike GB . Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI. Magn Reson Med 2001; 46: 923–931.

31.

31 Bieri O Scheffler K . Optimized balanced steady-state free precession magnetization transfer imaging. Magn Reson Med 2007; 58: 511–518.

32.

32 Bieri O Scheffler K . On the origin of apparent low tissue signals in balanced SSFD. Magn Reson Med 2006; 56: 1067–1074.